Ascend Wellness Holdings (AAWH) Change in Taxes (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Change in Taxes came in at $14.8 million in Q1 2026, up 4.95% year-on-year from $14.1 million in Q1 2025, and down 5.87% quarter-over-quarter from $15.7 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Change in Taxes (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Change in Taxes history runs 7 years deep, the most recent figure standing at $14.8 million for Q1 2026.
- On a quarterly basis, Change in Taxes rose 4.95% year-over-year to $14.8 million in Q1 2026; TTM through Mar 2026 was $55.6 million, a 26.38% decrease from a year earlier, with the FY2025 full-year figure at $54.9 million, down 28.91% from the prior year.
- Change in Taxes declined to $14.8 million in Q1 2026 per AAWH's latest filing, from $15.7 million in the prior quarter.
- Across five years, Change in Taxes topped out at $24.6 million in Q2 2024 and bottomed at -$19.5 million in Q4 2022.
- The 5-year median for Change in Taxes is $13.0 million (2023), against an average of $10.8 million.
- Across the five-year window, Change in Taxes sank 231.38% in 2022 and surged 17700.72% in 2024, its largest moves.
- Year by year, Change in Taxes stood at -$19.5 million in 2022, then soared by 166.72% to $13.0 million in 2023, then jumped by 76.7% to $22.9 million in 2024, then sank by 31.54% to $15.7 million in 2025, then slipped by 5.87% to $14.8 million in 2026.
- Per Business Quant, the three latest AAWH Change in Taxes figures stand at $14.8 million (Q1 2026), $15.7 million (Q4 2025), and $14.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | 73.00 Mn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -411.14 Mn |
| 5 | United Therapeutics | 23.01 Bn | 20.86 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.02 Bn | 22.02 Bn | - | - |
| 7 | Viatris | 20.40 Bn | 18.59 Bn | 1.16 Bn | -463.40 Mn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 119.80 Mn |
| 9 | Elanco Animal Health | 12.74 Bn | 12.31 Bn | 785.00 Mn | - |
| 10 | Ascend Wellness Holdings | 78.95 Mn | 18.03 Mn | 44.88 Mn | 14.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.79 Mn |
| Mar 31, 2026 | 14.79 Mn |
| Dec 31, 2025 | 15.71 Mn |
| Dec 31, 2025 | 15.71 Mn |
| Sep 30, 2025 | 14.57 Mn |
| Sep 30, 2025 | 14.57 Mn |
| Jun 30, 2025 | 10.49 Mn |
| Jun 30, 2025 | 10.49 Mn |
| Mar 31, 2025 | 14.09 Mn |
| Mar 31, 2025 | 14.09 Mn |
| Dec 31, 2024 | 22.95 Mn |
| Dec 31, 2024 | 22.95 Mn |
| Sep 30, 2024 | 13.87 Mn |
| Sep 30, 2024 | 13.87 Mn |
| Jun 30, 2024 | 24.57 Mn |
| Jun 30, 2024 | 24.57 Mn |
| Mar 31, 2024 | 15.80 Mn |
| Mar 31, 2024 | 15.80 Mn |
| Dec 31, 2023 | 12.99 Mn |
| Dec 31, 2023 | 12.99 Mn |